Osiris Therapeutics Revenue and Competitors

Columbia, MD USA

Location

$95M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Osiris Therapeutics's estimated annual revenue is currently $300M per year.(i)
  • Osiris Therapeutics's estimated revenue per employee is $1,685,393
  • Osiris Therapeutics's total funding is $95M.

Employee Data

  • Osiris Therapeutics has 178 Employees.(i)
  • Osiris Therapeutics grew their employee count by -1% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M620%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$11.3M73-10%N/AN/A
#6
$1.4M90%N/AN/A
#7
$1.9M129%N/AN/A
#8
$7.4M4817%N/AN/A
#9
$1.1M7-53%N/AN/A
#10
$1.1M70%N/AN/A
Add Company

Osiris Therapeutics, Inc., is a private development stage biotechnology company that develops adult mesenchymal stem cells (`MSCs") for the regeneration of bone marrow stroma, bone, cartilage and heart muscle tissues that have been damaged by injury, aging or degenerative disease. Osiris is also developing adult MSCs as a delivery platform for gene therapy.

keywords:N/A

$95M

Total Funding

178

Number of Employees

$300M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Osiris Therapeutics News

2022-04-17 - Global Stem Cells Market 2022 Growth Opportunities and ...

Osiris Therapeutics; NuVasive; Chiesi Pharmaceuticals; Medi-post; JCR Pharmaceutical; MolMed; Pharmicell; Anterogen; Takeda (TiGenix); CBR...

2022-04-17 - Stem Cell Therapy Market Size And Forecast | Osiris Therapeutics ...

Osiris Therapeutics Medipost Co. Ltd., Anterogen Co. Ltd., Pharmicell Co. Ltd., HolostemTerapieAvanzateSrl, JCR Pharmaceuticals Co.

2022-03-30 - Umbilical Cord Blood (UCB) Stem Cell Market size worth $ 12.06 ...

In April 2019, Osiris Therapeutics, Inc. Announces the Closing of Acquisition by Smith & Nephew plc through the consummation of a merger of...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$43.1M17829%N/A
#2
$30.3M179-14%N/A
#3
$15M17910%N/A
#4
$28.7M18044%N/A
#5
$19.9M181-18%N/A

Osiris Therapeutics Executives


NameTitle
Alla DanilkovitchChief Scientific Officer